Cargando…

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo

To overcome the harmful side effects, low tolerance, and undesirable outcomes of the anticancer drugs, we used ethane-1,2-diamine to bridge antitumoral (S)-3-acetyl-4-oxo-tetrahydroindolo[2,3-a]quinolizine-6-carboxylic acid (ATIQC) and tumor-targeting d-glucuronic acid, thereby providing (6S)-3-acet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xinyi, Wang, Yuji, Wu, Jianhui, Hu, Xi, Zhu, Haimei, Zhang, Xiaoyi, Wang, Yaonan, Gui, Lin, Zhao, Ming, Peng, Shiqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476604/ https://www.ncbi.nlm.nih.gov/pubmed/28652742 http://dx.doi.org/10.2147/IJN.S129989

Ejemplares similares

ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo
por: Wang, Yuji, et al.
Publicado: (2017)

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
por: Wu, Jianhui, et al.
Publicado: (2017)

Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis
por: Chen, Haiyan, et al.
Publicado: (2017)

BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral β-carboline-3-carboxylic acid
por: Wu, Jianhui, et al.
Publicado: (2019)

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis
por: Li, Shan, et al.
Publicado: (2015)

Dimethyl 2,2′-[2,2′-(ethane-1,1-diyl)bis(1H-indole-3,2-diyl)]-diacetate: a small molecule capable of nano-scale assembly, inhibiting venous thrombosis and inducing no bleeding side effect
por: Wang, Yaonan, et al.
Publicado: (2018)

IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis
por: Wu, Jianhui, et al.
Publicado: (2017)

Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao, Shurui, et al.
Publicado: (2019)

Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy
por: Wu, Jianhui, et al.
Publicado: (2015)

Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
por: Wu, Jianhui, et al.
Publicado: (2018)

Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
por: Li, Guanyu, et al.
Publicado: (2020)

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
por: Liu, Wenchao, et al.
Publicado: (2019)

Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
por: Zhang, Xiaoyi, et al.
Publicado: (2020)

Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy
por: Jiang, Xueyun, et al.
Publicado: (2015)

Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent
por: Zhu, Haimei, et al.
Publicado: (2017)

Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway
por: Zhang, Xiaoyi, et al.
Publicado: (2020)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
por: Chen, Haiyan, et al.
Publicado: (2018)

13-[CH(2)CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
por: Li, Guanyu, et al.
Publicado: (2019)

Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models
por: Feng, Qiqi, et al.
Publicado: (2021)

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis
por: Wang, Yuji, et al.
Publicado: (2015)

Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy
por: Lv, Xiaojie, et al.
Publicado: (2016)

Alsterpaullone, a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells through Apoptosis-Inducing Effect
por: Cui, Chunying, et al.
Publicado: (2013)

Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
por: Cui, Chunying, et al.
Publicado: (2013)

5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors
por: Gan, Taiping, et al.
Publicado: (2016)

RGD(F/S/V)-Dex: towards the development of novel, effective, and safe glucocorticoids
por: Jiang, Xueyun, et al.
Publicado: (2016)

Platelet‐inspired nanomedicine in hemostasis thrombosis and thromboinflammation
por: Raghunathan, Shruti, et al.
Publicado: (2022)

The melding of nanomedicine in thrombosis imaging and treatment: a review
por: Karagkiozaki, Varvara, et al.
Publicado: (2016)

Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo
por: Luo, Yifeng, et al.
Publicado: (2021)

Nanoparticles for multimodal in vivo imaging in nanomedicine
por: Key, Jaehong, et al.
Publicado: (2014)

DNA fragments binding CTCF in vitro and in vivo are capable of blocking enhancer activity
por: Didych, Dmitry A, et al.
Publicado: (2012)

Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with stiff nanogels
por: Li, Zheng, et al.
Publicado: (2023)

Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis
por: Ouyang, Boshu, et al.
Publicado: (2023)

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine
por: Chen, Feng, et al.
Publicado: (2015)

Bionanotechnology and Nanomedicine
por: Chase, P. Bryant, et al.
Publicado: (2012)

Nanoheterostructures (NHS) and Their Applications in Nanomedicine: Focusing on In Vivo Studies
por: Quarta, Alessandra, et al.
Publicado: (2019)

In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines
por: Lama, Sudeep, et al.
Publicado: (2020)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

Surfactant and Block Copolymer Nanostructures: From Design and Development to Nanomedicine Preclinical Studies
por: Kontogiannis, Orestis, et al.
Publicado: (2023)

In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines
por: Vaks, Lilach, et al.
Publicado: (2011)

Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines
por: Nguyen, Phuoc-Vinh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce7asv1n9hbseev1r53rpht0rn